Home
Who We Are
Who We Are
Testimonials
Collaborations
Consulting
Inspection Readiness
GxP Auditing
Quality Systems
Quality Risk Management
Monitoring Services
Training
GCP Training Services
Training Courses
DIGR-ACT
DIGR-ACT - Home
DIGR-ACT - About
DIGR-ACT - Contact Us
Online Store
Catalog
Blog
Contact

Clinical Pathways

Home
Who We Are
Who We Are
Testimonials
Collaborations
Consulting
Inspection Readiness
GxP Auditing
Quality Systems
Quality Risk Management
Monitoring Services
Training
GCP Training Services
Training Courses
DIGR-ACT
DIGR-ACT - Home
DIGR-ACT - About
DIGR-ACT - Contact Us
Online Store
Catalog
Blog
Contact
June 3, 2025
Guest User
Final Guidance Released on IRB Written ...

06/03/2025

-

In February 2025, the US Food and Drug Administration (FDA) and the Department of Health and Human Services (HHS) Office for Human Research Protection (OHRP) released the final guidance “Institutional Review Board (IRB) Written Procedures.”

Final Guidance Released on IRB Written Procedures
May 30, 2025
Guest User
Now Available: Clinical Pathways’ Major Changes ...

05/30/2025

-

In the ever changing world of clinical research, staying up to date with the latest guidelines and best practices is crucial. Our Major Changes in GCP from ICH E6(R2) to (R3): Road Map is designed for busy professionals who want to deepen their knowledge on GCP to help ensure they meet the highest standards of quality, safety, and compliance.

May 21, 2025
Guest User
FDA Draft Guidance on Considerations for AI Use

05/21/2025

-

In January 2025, the US Food and Drug Administration (FDA) published a draft guidance titled “Considerations for the Use of Artificial Intelligence (AI) to Support Regulatory Decision-Making for Drug and Biological Products” for trial sponsors and stakeholders intending to use AI to generate data and clinical evidence.

FDA Draft Guidance on Considerations for AI Use
April 30, 2025
Guest User
EMA on the use of Real-World Data/Evidence in ...

04/30/2025

-

In March, 2025, the European Medicines Agency (EMA) released a “Reflection paper on use of real-world data (RWD) in non-interventional studies (NIS) to generate real-world evidence (RWE) for regulatory purposes” as a guidance for stakeholders on quality planning, conduct and analysis of NISs that intend to use RWD to generate RWE.

EMA on the use of Real-World Data/Evidence in Non-Interventional Studies
April 22, 2025
Guest User
FDA Warning Letter to Sponsor – Records, ...

04/22/2025

-

In November 2024, the US Food and Drug Administration (FDA) issued a warning letter to the sponsor as a result of a BioResearch Monitoring Program (BIMO) inspection which observed objectionable conditions. The warning letter cited two violations of the Title 21 CFR.

FDA Warning Letter to Sponsor – Records, Reports, and Audit Trails
Sandra Sather
November 19, 2015

2016 Edition of International Compilation of Human Research Standards Now Available

Sandra Sather
November 19, 2015

11/19/2015

The Office for Human Research Protections (OHRP) has released the 2016 edition of the International Compilation of Human Research Standards. View them here and learn how they will affect our indstry!

Sandra Sather
September 21, 2015

Nov 19-20 iiBIG: Clinical Teamwork Conference Announced

Sandra Sather
September 21, 2015

09/21/2015

Join SAM Sather, and Clinical Pathways at the 2nd Annual Clinical Study Teamwork conference to be held November 19-20, 2015 in Cary, NC!

Sandra Sather
September 14, 2015

Our Work is for Their Future - 16th Annual ACRP RTP Chapter Fall Conference

Sandra Sather
September 14, 2015

09/14/2015

Join subject matter expert SAM Sather at the 16th Annual ACRP RTP Chapter Fall Conference October 8th and 9th. SAM is presenting Friday October 9th a 75 minute session on the "New FDA Informed Consent Draft Guidance: electronic Informed Consent and Information Sheet".

Sandra Sather
September 10, 2015

Re-envisioning the Federal Policy for the Protection of Human Subjects

Sandra Sather
September 10, 2015

09/10/2015

A major change is underway regarding the Federal Policy for the Protection of Human Subjects! Take a look here and find out how it could affect our industry.

Sandra Sather
September 7, 2015

New ICH E6 Good Clinical Practice (GCP) Updates!

Sandra Sather
September 7, 2015

09/07/2015

The long awaited new revisions to the ICH E6 GCP guidelines have been released! The European Medicines Agency (EMA) posted a version(s) for review.

Older Posts
 
Archive List
  • 2013 6
  • 2014 31
  • 2015 25
  • 2016 21
  • 2017 31
  • 2018 55
  • 2019 56
  • 2020 63
  • 2021 50
  • 2022 39
  • 2023 27
  • 2024 25
  • 2025 17

Subscribe to Blogs and Newsletters.

By signing up, you agree to our our Privacy Policy. You may unsubscribe from emails at any time.

Thank you! You will receive a confirmation email shortly.

Back to Top
Clinical Pathwaysinfo@clinicalpathwaysresearch.com

Cookie Notice | License Agreement | Privacy Policy | Return Policy | Terms and Conditions | Data Security Policy | Confidentiality Policy

© 2025 Clinical Pathways. All rights reserved.